Pharmafile Logo
Pharmafocus logo
Advanced Search

HIV

Showing 15 posts of 200 posts found.

gilead-sciences

Gilead’s Biktarvy maintains HIV suppression for 48 weeks in children and adolescents

March 7, 2019
Research and Development Biktarvy, Gilead, HIV, pharma

Gilead has lifted the curtain on new Phase 2/3 efficacy data for Biktarvy (bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide 25 …

News
scotland-2016-aerial-clackmannan_tower_01

Scottish biotech secures initial orders for HIV diagnosis kit from Indonesia, Moldova and Papua New Guinea

March 7, 2019
Business Services, Medical Communications, Research and Development, Sales and Marketing Diagnostics, HIV, Indonesia, Moldova, Scotland, developing coutnries

A small biotech based in Clackmannanshire, Scotland expects to turnover an additional £20 million from sales of its HIV diagnostics …

News
1920px-hiv-budding-color

London man becomes second in world to be cured of HIV

March 5, 2019
Manufacturing and Production Berlin Patient, CCR5, HIV, He Jiankui, London Patient

A man in Britain has become the second person in the world to be ‘cured’ of HIV, after receiving a …

News
pharmafocus_march_2019_cover

Read the March 2019 issue of Pharmafocus online now!

February 26, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Drug pricing, HIV, Trump, WHO, brexit, depression, mental health, pharmacovigilance, rare disease

Just one month to go until Brexit here in the UK, and it’s still all to play for. After months …

News

Genetically modified twins may have been altered in a way that improves memory and cognition

February 22, 2019
Medical Communications CCR5, HIV, cognitive enhancement, crispr, gene editing

The twins who were genetically modified using the gene editing tool CRISPR may have been changed in a way that …

News

Researchers develop new, more effective method for detection of HIV virus genomes

February 8, 2019
Medical Communications, Research and Development HIV, University of Texas, pharma

A team of researchers have devised a new way to accurately detect residual HIV in the body’s immune cells, allowing …

News

HIV drug holds hope for Alzheimer’s after significantly reducing inflammation in mice

February 7, 2019
Research and Development HIV, dementia, inflamation

Lamivudine, a generic drug for HIV, significantly reduces age-related inflammation and other signs of aging in mice, according to a …

News
6813384933_1fb31d73fb_z

Health Secretary pledges to end transmission of HIV in England by 2030

January 31, 2019
Medical Communications, Research and Development 2030, AIDS, England, HIV, UN, health

Through better prevention, detection and treatment, Health Secretary Matt Hancock has pledged to end transmission of HIV in England by …

News

Global Fund seeks £11bn as progress slows in fight against malaria, TB and HIV

January 14, 2019
Sales and Marketing Africa, Global Fund, HIV, TB, infectious diseases, malaria, tuberculosis

The Global Fund is seeking £11 billion worth of investment in an attempt to save 16 million lives in the …

News
1920px-hiv-budding-color

Trump administration block NIH researchers from using foetal tissue, disrupting research to cure HIV

December 10, 2018
Sales and Marketing HIV, Trump, US government, feotal tissue, mice, research

The Trump Administration has halted the acquisition of new human foetal tissue for use in experiments conducted by NIH researchers, …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

November 30, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HIV, Immuno Biotech, NHS, Roche, autism, biosimilars, pharma, top ten

We’ve come to the end of November, and with only one month of the year left to go, the industry …

News
merckwindow_web

MSD chalks up two HIV drug approvals in Europe

November 30, 2018
Medical Communications, Sales and Marketing Delstrigo, EU, Europe, HIV, MSD, Pifeltro, pharma

MSD has announced the European approval of two of its products for the treatment of HIV: the single-tablet combination Delstrigo …

News

UK is among the first to meet UN targets for HIV treatment and prevention, Public Health England says

November 29, 2018
Medical Communications HIV, UK, pharma

The UK is among the first countries in the world to meet the HIV treatment targets set out by the …

News

Immuno Biotech owner promoting unlicensed ‘cure’ for cancer, autism and HIV to be sentenced next week

November 23, 2018
Medical Communications Cancer, David Noakes, GcMAF, HIV, UKIP, autism

The owner of Guernsey-based biotech Immuno Biotech Ltd, David Noakes, will be sentenced this week after admitting to a number …

News
gsk_china_8

GSK announces results of three year trial into long-lasting HIV injection

October 30, 2018
Manufacturing and Production GSK, HIV, drugs, injection, medication

GlaxoSmithKline have announced the results of a three year investigation into a long acting, injectable, two-drug HIV regimen at the …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026